Celcuity (CELC) Convertible Debt (2022 - 2026)
Celcuity's (CELC) quarterly Convertible Debt came in at $130.0 million in Q4 2025, up 30.0% YoY from $100.0 million in Q4 2024, and little changed on a QoQ basis from $130.0 million in Q3 2025.
Celcuity (CELC) Convertible Debt (2022 - 2026) Analysis & Trends
Celcuity (CELC) has 4 years of Convertible Debt data on file, last reported at $130.0 million in Q4 2025.
- Quarterly Convertible Debt rose 30.0% year-over-year to $130.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $130.0 million (up 30.0% YoY) and the FY2025 annual result came in at $130.0 million, up 30.0% from the prior year.
- Convertible Debt held at $130.0 million in Q4 2025, from $130.0 million in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $130.0 million in Q3 2025 to a low of $35.0 million in Q4 2022.
- A 4-year average of $86.5 million and a median of $100.0 million in 2024 frame the typical range for Convertible Debt.
- Annual changes were most pronounced in 2023 — Convertible Debt changed 0.0% — and 2024, when it surged 185.71%.
- Tracing CELC's Convertible Debt over 4 years: stood at $35.0 million in 2022, then changed by 0.0% to $35.0 million in 2023, then surged by 185.71% to $100.0 million in 2024, then increased by 30.0% to $130.0 million in 2025.
- The last three Convertible Debt figures came in at $130.0 million (Q4 2025), $130.0 million (Q3 2025), and $100.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Celcuity | 4.50 Bn | 4.50 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 753.24 Mn |
| Dec 31, 2025 | 130.00 Mn |
| Sep 30, 2025 | 130.00 Mn |
| Jun 30, 2025 | 100.00 Mn |
| Mar 31, 2025 | 100.00 Mn |
| Dec 31, 2024 | 100.00 Mn |
| Sep 30, 2024 | 100.00 Mn |
| Jun 30, 2024 | 100.00 Mn |
| Mar 31, 2024 | 35.00 Mn |
| Dec 31, 2023 | 35.00 Mn |
| Dec 31, 2022 | 35.00 Mn |